<h1>Branded cough syrup seized after child deaths; lab finds 48.6% diethylene glycol; action under Drugs and Cosmetics Act</h1> State authorities banned the sale and ordered seizure of a branded cough syrup after 14 children died of suspected renal failure and laboratory testing found 48.6% diethylene glycol in a product sample, deeming it not of standard quality. The regulator directed removal of other products from the same manufacturer pending tests and initiated action under the Drugs and Cosmetics Act. Financial relief was announced for victims' families. Central drug authorities launched risk-based inspections of multiple drug manufacturing units and a multi-agency technical team is analysing clinical and product samples to determine cause and scope and to identify regulatory or criminal culpability.